Contractor directory
UEI MS6UM2NBDW91 · CAGE 4BX80

Immedica Pharma US Inc.

Immedica Pharma US Inc. received $0 in federal prime contract obligations in the 12 months ending Oct 5, 2026, and $12.3M since FY2022. Its largest customer is the Department of Health and Human Services.

Obligations, latest 12 months
$0
Since FY2022
$12.3M
1 awards
Awards with activity
0
Latest 12 months
Most recent action
Aug 12, 2024
First seen Mar 22, 2022

Contractor details

Unique Entity ID (UEI)
MS6UM2NBDW91
CAGE code
4BX80
Headquarters
Radnor, PA
Business size
Small Business

As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.

Obligations by fiscal year

Net prime contract obligations by federal fiscal year.

FY2022
$12.3M
FY2023
$0
FY2024
$0

Top agencies

Funding agencies ranked by obligations since FY2022.

Funding agencyLatest 12 moSince FY2022
Department of Health and Human Services$0$12.3M

Top NAICS codes

Industry codes agencies recorded on this contractor's awards, since FY2022.

NAICSIndustryLatest 12 moSince FY2022
325412Pharmaceutical Preparation Manufacturing$0$12.3M

What it sells

Product and service codes (PSC) on this contractor's awards, since FY2022.

PSCDescriptionSince FY2022
6505Drugs and Biologicals$12.3M

Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.

Ready to win more?

Ready to connect your pursuit work?

GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.